Showing results (101-110 of 501) with videos related to

Sort By:
Pageof 51
BMJ Neurology Open|August 28, 2023
Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trialAmarjeet Tank, S Claiborne Johnston, Ritika Jain, et al.
BMJ Neurology Open|June 29, 2026
Working years lost in people with epilepsy according to underlying aetiology: a population-based cohort studyJulie Werenberg Dreier, Betina B Trabjerg, Kasper Lolk, et al.
BMJ Neurology Open|July 6, 2026
Association of coronary artery bypass with cognitive impairment in coronary artery disease across APO (ε) genotypes in AllofUSPraveen Hariharan, Minoo Bagheri, Emelia Asamoah, et al.
BMJ Neurology Open|May 28, 2026
Health inequalities in outpatient neurological conditions across a large UK urban population: a retrospective observational study using automated codingKeira Markey, Robyn Hamilton, Rohan Ahmed, et al.
BMJ Neurology Open|May 20, 2026
Amyloid-β-related angiitis presenting as leptomeningitisPablo Gómez-Porro, Beatriz De La Puente, Lorena Fernández, et al.
BMJ Neurology Open|May 21, 2026
Correlation of cerebrospinal fluid IL-6 as a marker of disease activity in patients with longitudinally extensive transverse myelitisSangam Singh, Ajai Kumar Singh, Pradeep Kumar Maurya, et al.
BMJ Neurology Open|May 7, 2026
A mixed-methods study of patient perspectives on antiseizure medication discontinuation attempts after a period of seizure-freedomSamuel W Terman, Jordan M Silva, Max Kuster, et al.
BMJ Neurology Open|May 7, 2026
Impact of X-linked dystonia-parkinsonism on caregiver strain, anxiety and depressionPaulo Cataniag, Jed Noel Ong, Cid Czarina Diesta
BMJ Neurology Open|May 7, 2026
Associations of chrononutrition and sleep with fatigue in multiple sclerosis: an analysis of the Swiss Multiple Sclerosis RegistryNicholas E Phillips, Vladeta Ajdacic-Gross, Jessica Rebeaud, et al.
BMJ Neurology Open|August 15, 2026
Comparison of double-blind and open-label decline rates in lecanemab and donanemab trials in Alzheimer's diseaseAlok K Dwivedi, Bruno P Imbimbo, Jesus Abanto, et al.
Pageof 51